Table 2.
Factor | Mechanism | Reference |
---|---|---|
KLF4, BLIMP1 | Stimulates LMP1, then works with LMP1 to activate BZLF1 and BRLF1 expression | [127,128,129] |
BCR signaling | Stimulates EBV reactivation | [130] |
PI3K signaling | Stimulates BZLF1 promoter | [139] |
IRF8 | Influences caspase activity and KAP1 cleavage | [141] |
Chaetocin | Stimulates ROS production | [143] |
EBV upregulation of NADPH oxidase genes | Stimulates ROS production | [146] |
NRF2 upregulation | Prevents ROS-mediated cell death | [146] |
LMP1 | Stimulates ROS production | [146] |
LMP1 and LMP2A | Promote NRF2 production and translocation to nucleus | [147] |
AKT | Involved in LMP1/LMP2A/NRF2 signaling | [148] |
miRNA-18a | Stimulates transition from G1 to S phase | [148] |
Hypoxia | Stimulates reactivation | [148] |
Mycophenolate mofetil (immunosuppressant) | Impairs Vδ2+ T cell recovery | [155] |
Syphilis | Cross-links TLR2 and BCR | [157] |
HPV | E6 and E7 ** stimulates reactivation | [158,159] |
As2O3 * | Stimulates BZLF1 transcription | [166,167] |
Radiation | Induces BZLF1 and BLLF | [168] |
* Conflicting evidence. ** E7 inhibited reactivation in immortalized keratinocytes.